MedWatch Alert ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone.  The two recently published studies looked at whether there is a higher risk of blood clots in women taking birth control pills containing the progestin drospirenone […]

Continue reading about Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots